Centogene NV Ordinary Shares CNTG
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if CNTG is a good fit for your portfolio.
News
-
Del, Nutanix, Nio, Elastic and MongoDB shares rally while Broadcom's stock falls, and more moving shares
-
Centogene shares climb after study confirms biomarker for Gaucher disease
-
Delta Air Lines, Generac stocks rally, Walgreens and Lordstown Motors shares tumble, and other stocks on the move
-
Centogene shares jump on joint venture with Lifera
-
Centogene Extends Genetic Testing Partnership With Takeda
Trading Information
- Previous Close Price
- $0.48
- Day Range
- $0.45–0.49
- 52-Week Range
- $0.43–1.98
- Bid/Ask
- $0.46 / $0.49
- Market Cap
- $13.62 Mil
- Volume/Avg
- 6,941 / 61,985
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.25
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Centogene NV is a United States-based company focused on transforming clinical and genetic data into actionable information for patients, physicians, and pharmaceutical companies. The company operates in three segments: pharmaceutical, diagnostics, and COVID-19. Its pharmaceutical segment provides a variety of services to its pharmaceutical partners, including early patient recruitment and identification, epidemiological insights, biomarker discovery, and patient monitoring. Its clinical diagnostics segment provides targeted genetic sequencing and diagnostics services to patients.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Small Value
- Total Number of Employees
- 517
- Website
- https://www.centogene.com
Valuation
|
Metric
|
CNTG
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | 0.25 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
CNTG
|
|---|---|
Quick Ratio | 1.19 |
Current Ratio | 1.45 |
Interest Coverage | −9.17 |
Quick Ratio
CNTG
Profitability
|
Metric
|
CNTG
|
|---|---|
Return on Assets (Normalized) | −42.81% |
Return on Equity (Normalized) | −820.67% |
Return on Invested Capital (Normalized) | −56.87% |
Return on Assets
CNTG
Diagnostics & Research Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
TMO
| Thermo Fisher Scientific Inc | Hxysmpnp | Kgjr | $209.3 Bil | |
DHR
| Danaher Corp | Srbrsshhg | Cjhfrd | $182.1 Bil | |
IQV
| IQVIA Holdings Inc | Jbdzwhxy | Fpzkbwn | $42.8 Bil | |
IDXX
| IDEXX Laboratories Inc | Fjdggnxzvd | Jlcnmzy | $41.5 Bil | |
A
| Agilent Technologies Inc | Vnbnqqbkbg | Dcnp | $40.4 Bil | |
MTD
| Mettler-Toledo International Inc | Jsjfhwwnt | Bcknxp | $26.5 Bil | |
ICLR
| Icon PLC | Vfmtdwnt | Wrjzcld | $24.8 Bil | |
ILMN
| Illumina Inc | Vjjhgln | Bzzygp | $19.5 Bil | |
WAT
| Waters Corp | Fltlssfrzc | Hhq | $18.5 Bil | |
LH
| Laboratory Corp of America Holdings | Vsvnthtlt | Pmvdn | $16.7 Bil |